Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-19

Clinical Trial Update: The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response [NA]

View source ↗

Summary

A completed clinical trial investigating how preceding LPS administration affects the Fluenz-induced innate immune response and immune tolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluenz
  • lipopolysaccharide (lipopolysaccharide)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Innate Immune Response, Immune Tolerance | NA | Status: COMPLETED | Results posted: 2019-04-19